Evidence map›Paper›PMID 42670412›Full record

ArticleCureus2026

Atypical Sjögren-Like Presentation as a Paraneoplastic Manifestation of Metastatic Parotid Adenocarcinoma.

Carlos Berrocal, Isabella Libreros Mejia, Raúl Vallejo-Serna, Bryan David Zamora Segura, Jose Luis Pineda Bocanegra, Gisella Barrios Torrejano, Mariana Ariza Martinez, Nilton Adrián Arias Molina, Lena Isabel Barrera Vergara

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Carlos BerrocalInternal Medicine, Universidad del Valle, Cali, COL.
Isabella Libreros MejiaGeneral Medicine, Universidad Libre, Cali, COL.
Raúl Vallejo-SernaInternal Medicine, See outside Hospital Universitario del Valle Evaristo García ESE, Cali, COL.
Bryan David Zamora SeguraInternal Medicine, Universidad del Valle, Cali, COL.
Jose Luis Pineda BocanegraInternal Medicine, Hospital San Jerónimo ESE, Montería, COL.
Gisella Barrios TorrejanoGeneral Medicine, Clínica Materno Infantil Casa del Niño, Montería, COL.
Mariana Ariza MartinezGeneral Medicine, Clínica IMAT Oncomédica Auna, Montería, COL.
Nilton Adrián Arias MolinaPathology, Universidad del Valle, Cali, COL.
Lena Isabel Barrera VergaraInternal Medicine, Centro para el Desarrollo y Evaluación de Políticas y Tecnología en Salud Pública (CEDETES), Cali, COL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paraneoplastic Sjögren-like syndrome is a rare extraglandular manifestation of occult malignancy that can closely mimic primary autoimmune disease, leading to delayed diagnosis of the underlying neoplasm. While most reported cases are associated with hematological malignancies, its occurrence in the context of solid tumors, particularly salivary gland carcinomas, is exceptionally rare and poorly characterized. We report a 43-year-old male presenting with progressive dyspnea, constitutional symptoms, and severe polyserositis, initially suggestive of primary Sjögren's syndrome (SS) based on objective sicca findings, including severely reduced lacrimal secretion on the Schirmer test and clinically observed asialia, in conjunction with positive anti-SSA antibodies. Imaging showed persistent pulmonary lesions and pleural effusions, while bronchoalveolar lavage revealed markedly elevated galactomannan levels, suggesting probable pulmonary aspergillosis. Despite immunosuppressive therapy, no clinical improvement was observed. Further evaluation, including surgical biopsy, demonstrated metastatic adenocarcinoma of probable salivary gland origin. The final diagnosis was stage IV parotid adenocarcinoma with pulmonary metastases and paraneoplastic Sjögren-like syndrome. The patient received one cycle of chemotherapy but subsequently deteriorated and died. Paraneoplastic Sjögren-like syndrome is exceptionally rare and characterized by heterogeneous clinical presentations, often lacking classic histopathological findings. Red flags such as rapid progression, systemic involvement, and poor response to standard therapy should prompt evaluation for occult malignancy. This case highlights the importance of recognizing atypical Sjögren-like presentations as a probable paraneoplastic phenomenon. Early identification of warning signs may facilitate timely diagnosis of underlying malignancy and impact clinical outcomes.

Indexed as

anti-ssa/ro antibodiesparaneoplastic syndromeparotid neoplasmspolyserositissalivary gland tumorssjögren syndrome

Identifiers

PMID42670412
PMCPMC13526316

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.